Cancer Management and Research
Volume 13, 2021 - Issue
Open access
109
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms
Shengming Deng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Zhiyao Fan1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Huanyu Xia1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Yitao Gong1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Yunzhen Qian1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Qiuyi Huang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, He Cheng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Kaizhou Jin1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Zhiwen Xiao1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Guopei Luo1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
, Xianjun Yu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China
& Chen Liu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
show all
Pages 107-115
|
Published online: 08 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.